Literature DB >> 16254348

Association of human immunodeficiency virus type 1 gag with membrane does not require highly basic sequences in the nucleocapsid: use of a novel Gag multimerization assay.

Akira Ono1, Abdul A Waheed, Anjali Joshi, Eric O Freed.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) particle production, a process driven by the Gag polyprotein precursor, occurs on the plasma membrane in most cell types. The plasma membrane contains cholesterol-enriched microdomains termed lipid rafts, which can be isolated as detergent-resistant membrane (DRM). Previously, we and others demonstrated that HIV-1 Gag is associated with DRM and that disruption of Gag-raft interactions impairs HIV-1 particle production. However, the determinants of Gag-raft association remain undefined. In this study, we developed a novel epitope-based Gag multimerization assay to examine whether Gag assembly is essential for its association with lipid rafts. We observed that membrane-associated, full-length Gag is poorly detected by immunoprecipitation relative to non-membrane-bound Gag. This poor detection is due to assembly-driven masking of Gag epitopes, as denaturation greatly improves immunoprecipitation. Gag mutants lacking the Gag-Gag interaction domain located in the N terminus of the nucleocapsid (NC) were efficiently immunoprecipitated without denaturation, indicating that the epitope masking is caused by higher-order Gag multimerization. We used this assay to examine the relationship between Gag assembly and Gag binding to total cellular membrane and DRM. Importantly, a multimerization-defective NC mutant displayed wild-type levels of membrane binding and DRM association, indicating that NC-mediated Gag multimerization is dispensable for association of Gag with membrane or DRM. We also demonstrate that different properties of sucrose and iodixanol membrane flotation gradients may explain some discrepancies regarding Gag-raft interactions. This report offers new insights into the association of HIV-1 Gag with membrane and with lipid rafts.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16254348      PMCID: PMC1280195          DOI: 10.1128/JVI.79.22.14131-14140.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  99 in total

1.  The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines.

Authors:  N Srinivasakumar; N Chazal; C Helga-Maria; S Prasad; M L Hammarskjöld; D Rekosh
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Inhibition of human immunodeficiency virus type 1 particle formation by alterations of defined amino acids within the C terminus of the capsid protein.

Authors:  B Kattenbeck; A von Poblotzki; A Rohrhofer; H Wolf; S Modrow
Journal:  J Gen Virol       Date:  1997-10       Impact factor: 3.891

3.  A putative alpha-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assembly.

Authors:  M A Accola; S Höglund; H G Göttlinger
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

4.  Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein.

Authors:  T R Gamble; S Yoo; F F Vajdos; U K von Schwedler; D K Worthylake; H Wang; J P McCutcheon; W I Sundquist; C P Hill
Journal:  Science       Date:  1997-10-31       Impact factor: 47.728

5.  In vitro assembly of virus-like particles with Rous sarcoma virus Gag deletion mutants: identification of the p10 domain as a morphological determinant in the formation of spherical particles.

Authors:  S Campbell; V M Vogt
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

6.  Multimerization of human immunodeficiency virus type 1 Gag promotes its localization to barges, raft-like membrane microdomains.

Authors:  O W Lindwasser; M D Resh
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

7.  Analysis of the assembly function of the human immunodeficiency virus type 1 gag protein nucleocapsid domain.

Authors:  Y Zhang; H Qian; Z Love; E Barklis
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

8.  Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism.

Authors:  P Spearman; R Horton; L Ratner; I Kuli-Zade
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

9.  Effects of nucleocapsid mutations on human immunodeficiency virus assembly and RNA encapsidation.

Authors:  Y Zhang; E Barklis
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

10.  The I domain is required for efficient plasma membrane binding of human immunodeficiency virus type 1 Pr55Gag.

Authors:  S Sandefur; V Varthakavi; P Spearman
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

View more
  65 in total

Review 1.  Properties and functions of the nucleocapsid protein in virus assembly.

Authors:  Delphine Muriaux; Jean-Luc Darlix
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

2.  Membrane Binding of the Rous Sarcoma Virus Gag Protein Is Cooperative and Dependent on the Spacer Peptide Assembly Domain.

Authors:  Robert A Dick; Marilia Barros; Danni Jin; Mathias Lösche; Volker M Vogt
Journal:  J Virol       Date:  2015-12-16       Impact factor: 5.103

3.  Quantitative fluorescence resonance energy transfer microscopy analysis of the human immunodeficiency virus type 1 Gag-Gag interaction: relative contributions of the CA and NC domains and membrane binding.

Authors:  Ian B Hogue; Adam Hoppe; Akira Ono
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

4.  Membrane structure correlates to function of LLP2 on the cytoplasmic tail of HIV-1 gp41 protein.

Authors:  Alexander L Boscia; Kiyotaka Akabori; Zachary Benamram; Jonathan A Michel; Michael S Jablin; Jonathan D Steckbeck; Ronald C Montelaro; John F Nagle; Stephanie Tristram-Nagle
Journal:  Biophys J       Date:  2013-08-06       Impact factor: 4.033

Review 5.  Relationships between plasma membrane microdomains and HIV-1 assembly.

Authors:  Akira Ono
Journal:  Biol Cell       Date:  2010-03-25       Impact factor: 4.458

6.  Mutation of dileucine-like motifs in the human immunodeficiency virus type 1 capsid disrupts virus assembly, gag-gag interactions, gag-membrane binding, and virion maturation.

Authors:  Anjali Joshi; Kunio Nagashima; Eric O Freed
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

Review 7.  How HIV-1 Gag assembles in cells: Putting together pieces of the puzzle.

Authors:  Jaisri R Lingappa; Jonathan C Reed; Motoko Tanaka; Kasana Chutiraka; Bridget A Robinson
Journal:  Virus Res       Date:  2014-07-24       Impact factor: 3.303

8.  Effect of dimerizing domains and basic residues on in vitro and in vivo assembly of Mason-Pfizer monkey virus and human immunodeficiency virus.

Authors:  Karolína Bohmová; Romana Hadravová; Jitka Stokrová; Roman Tuma; Tomás Ruml; Iva Pichová; Michaela Rumlová
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

9.  Functional replacement of a retroviral late domain by ubiquitin fusion.

Authors:  Anjali Joshi; Utpal Munshi; Sherimay D Ablan; Kunio Nagashima; Eric O Freed
Journal:  Traffic       Date:  2008-08-09       Impact factor: 6.215

10.  HIV-1 Gag associates with specific uropod-directed microdomains in a manner dependent on its MA highly basic region.

Authors:  G Nicholas Llewellyn; Jonathan R Grover; Balaji Olety; Akira Ono
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.